[Antinuclear antibodies in systemic autoimmune disease]

Area of Science:

• Immunology
• Clinical Diagnostics
• Autoimmune Diseases

Background:

• Antinuclear antibodies (ANA) are crucial biomarkers for diagnosing systemic autoimmune diseases, including systemic lupus erythematosus (SLE).
• Indirect immunofluorescence (IIF) using HEp-2 cells is a common method for ANA detection, offering high sensitivity but limited specificity.
• ANA can be present in healthy individuals and those with non-autoimmune conditions, potentially leading to false-positive results.

Purpose of the Study:

• To evaluate the diagnostic utility of ANA testing in systemic autoimmune diseases.
• To highlight the limitations of HEp-2 IIF for ANA detection, particularly regarding specificity.
• To emphasize the importance of specific autoantibody testing for certain autoimmune conditions.

Main Methods:

• Review of indirect immunofluorescence (IIF) for antinuclear antibody (ANA) detection.
• Analysis of diagnostic support provided by antibodies against double-stranded (ds) DNA and standard extractable nuclear antigens (ENA).
• Evaluation of disease-specific antigen panels, such as myositis panels for idiopathic inflammatory myopathy (IIM).

Main Results:

• HEp-2 IIF ANA testing demonstrates high sensitivity for systemic autoimmune diseases but is limited by specificity.
• ANA detection via HEp-2 IIF requires careful clinical correlation to avoid misdiagnosis.
• Direct antibody testing against specific antigens (e.g., ENA, myositis panel) can be more effective for certain autoimmune diseases like Sjögren's syndrome and IIM.

Conclusions:

• ANA testing, particularly by HEp-2 IIF, should be guided by clinical suspicion due to potential false positives.
• For specific autoimmune conditions such as Sjögren's syndrome and idiopathic inflammatory myopathy (IIM), direct autoantibody testing offers improved diagnostic accuracy.
• Complementary autoantibody testing enhances the diagnosis of systemic autoimmune diseases beyond general ANA screening.